Warning (2) : Undefined array key "profile" [in /var/www/vhosts/marketcap.tools/httpdocs/src/Controller/HomesController.php, line 242]
Warning (2) : Trying to access array offset on value of type null [in /var/www/vhosts/marketcap.tools/httpdocs/src/Controller/HomesController.php, line 242]
Warning (2) : Undefined array key "profile" [in /var/www/vhosts/marketcap.tools/httpdocs/src/Controller/HomesController.php, line 243]
Warning (2) : Trying to access array offset on value of type null [in /var/www/vhosts/marketcap.tools/httpdocs/src/Controller/HomesController.php, line 243]
Warning (512) : Unable to emit headers. Headers sent in file=/var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Error/Renderer/HtmlErrorRenderer.php line=36 [in /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Http/ResponseEmitter.php, line 71]
Warning (2) : Cannot modify header information - headers already sent by (output started at /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Error/Renderer/HtmlErrorRenderer.php:36) [in /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Http/ResponseEmitter.php, line 164]
Warning (2) : Cannot modify header information - headers already sent by (output started at /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Error/Renderer/HtmlErrorRenderer.php:36) [in /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Http/ResponseEmitter.php, line 197]
Warning (2) : Cannot modify header information - headers already sent by (output started at /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Error/Renderer/HtmlErrorRenderer.php:36) [in /var/www/vhosts/marketcap.tools/httpdocs/vendor/cakephp/cakephp/src/Http/ResponseEmitter.php, line 236]
Sarepta Therapeutics, Inc. - Market capitalization
companies: 6,640     total market cap: $100.73 T
Sarepta Therapeutics, Inc.
SRPT

$10.59 B
Marketcap
$110.86
Share price
US
Country
N/A
Change (1 day)
N/A
Year High
N/A
Year Low
Biotechnology
Categories

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

marketcap

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools